Risk management specialist

Medical device risk management specialist implementing ISO 14971 throughout product lifecycle.

How to use it

Claude Code
  1. Run the line below. It pulls the whole folder into ~/.claude/skills/risk-management-specialist, including the files SKILL.md points to.
  2. Describe your job in plain words. Claude Code follows the skill from there.
Claude Code — installs the whole folder, not just SKILL.md
npx degit alirezarezvani/claude-skills/ra-qm-team/skills/risk-management-specialist#main ~/.claude/skills/risk-management-specialist

For one project only, change the path to .claude/skills/risk-management-specialist. This skill also uses risk_matrix_calculator.py, iso14971-implementation-guide.md, risk-analysis-methods.md — copying SKILL.md alone won't be enough. See the folder on GitHub.

Claude (web or desktop app)
  1. On this page open ⋯ → Download .md.
  2. Save it as SKILL.md in a folder, zip the folder, then Customize → Skills → + → Create skill → Upload a skill.
  3. Pick the file and Save. Claude shows the name and description and runs a security scan.
  4. Check the skill is switched on.
  5. Start a new chat and describe your job in plain words. The AI follows the skill from there.
ChatGPT or another app
  1. ChatGPT: make a Project and paste it into Instructions.
  2. Neither? Paste it at the top of a new chat — it works for that chat.
Not working?
  • Check which app you pasted it into — the steps above name the right one.
  • Some skills need the paid tier of Claude or ChatGPT.
Step-by-step guide with screenshots · Ask in the forum

Paste into Claude, ChatGPT or Cursor.

Source of Risk management specialist

Show the full text456 lines
namedescription
risk-management-specialistMedical device risk management specialist implementing ISO 14971 throughout product lifecycle. Provides risk analysis, risk evaluation, risk control, and post-production information analysis. Use when user mentions risk management, ISO 14971, risk analysis, FMEA, fault tree analysis, hazard identification, risk control, risk matrix, benefit-risk analysis, residual risk, risk acceptability, or post-market risk.

Risk Management Specialist

ISO 14971:2019 risk management implementation throughout the medical device lifecycle.


Table of Contents


Risk Management Planning Workflow

Establish risk management process per ISO 14971.

Workflow: Create Risk Management Plan
  1. Define scope of risk management activities:
    • Medical device identification
    • Lifecycle stages covered
    • Applicable standards and regulations
  2. Establish risk acceptability criteria:
    • Define probability categories (P1-P5)
    • Define severity categories (S1-S5)
    • Create risk matrix with acceptance thresholds
  3. Assign responsibilities:
    • Risk management lead
    • Subject matter experts
    • Approval authorities
  4. Define verification activities:
    • Methods for control verification
    • Acceptance criteria
  5. Plan production and post-production activities:
    • Information sources
    • Review triggers
    • Update procedures
  6. Obtain plan approval
  7. Establish risk management file
  8. Validation: Plan approved; acceptability criteria defined; responsibilities assigned; file established
Risk Management Plan Content
Section Content Evidence
Scope Device and lifecycle coverage Scope statement
Criteria Risk acceptability matrix Risk matrix document
Responsibilities Roles and authorities RACI chart
Verification Methods and acceptance Verification plan
Production/Post-Production Monitoring activities Surveillance plan
Risk Acceptability Matrix (5x5)
Probability \ Severity Negligible Minor Serious Critical Catastrophic
Frequent (P5) Medium High High Unacceptable Unacceptable
Probable (P4) Medium Medium High High Unacceptable
Occasional (P3) Low Medium Medium High High
Remote (P2) Low Low Medium Medium High
Improbable (P1) Low Low Low Medium Medium
Risk Level Actions
Level Acceptable Action Required
Low Yes Document and accept; still reduce as far as possible (EU MDR)
Medium After reduction AFAP Reduce as far as possible; document why further reduction is impossible
High After reduction AFAP Reduction required; demonstrate all further options exhausted
Unacceptable No Design change mandatory

EU MDR — AFAP, not ALARP: For CE-marked devices, risks must be reduced as far as possible (AFAP) without economic considerations (MDR Annex I, GSPR 1–4; EN ISO 14971:2019/A11:2021 Z-annexes deviation). ALARP ("as low as reasonably practicable"), which permits cost-benefit weighing in acceptability decisions, is not an acceptable criterion under the EU MDR — a notified body will flag it. ISO 14971:2019 itself removed ALARP from the normative text. ALARP may persist in some non-EU jurisdictions (e.g., the UK HSE tradition); if used outside the EU, flag the deviation from EU requirements explicitly.


Risk Analysis Workflow

Identify hazards and estimate risks systematically.

Workflow: Conduct Risk Analysis
  1. Define intended use and reasonably foreseeable misuse:
    • Medical indication
    • Patient population
    • User population
    • Use environment
  2. Select analysis method(s):
    • FMEA for component/function analysis
    • FTA for system-level analysis
    • HAZOP for process deviations
    • Use Error Analysis for user interaction
  3. Identify hazards by category:
    • Energy hazards (electrical, mechanical, thermal)
    • Biological hazards (bioburden, biocompatibility)
    • Chemical hazards (residues, leachables)
    • Operational hazards (software, use errors)
  4. Determine hazardous situations:
    • Sequence of events
    • Foreseeable misuse scenarios
    • Single fault conditions
  5. Estimate probability of harm (P1-P5)
  6. Estimate severity of harm (S1-S5)
  7. Document in hazard analysis worksheet
  8. Validation: All hazard categories addressed; all hazards documented; probability and severity assigned
Hazard Categories Checklist
Category Examples Analyzed
Electrical Shock, burns, interference ☐
Mechanical Crushing, cutting, entrapment ☐
Thermal Burns, tissue damage ☐
Radiation Ionizing, non-ionizing ☐
Biological Infection, biocompatibility ☐
Chemical Toxicity, irritation ☐
Software Incorrect output, timing ☐
Use Error Misuse, perception, cognition ☐
Environment EMC, mechanical stress ☐
Analysis Method Selection
Situation Recommended Method
Component failures FMEA
System-level failure FTA
Process deviations HAZOP
User interaction Use Error Analysis
Software behavior Software FMEA
Early design phase PHA
Probability Criteria
Level Name Description Frequency
P5 Frequent Expected to occur >10⁻³
P4 Probable Likely to occur 10⁻³ to 10⁻⁴
P3 Occasional May occur 10⁻⁴ to 10⁻⁵
P2 Remote Unlikely 10⁻⁵ to 10⁻⁶
P1 Improbable Very unlikely <10⁻⁶
Severity Criteria
Level Name Description Harm
S5 Catastrophic Death Death
S4 Critical Permanent impairment Irreversible injury
S3 Serious Injury requiring intervention Reversible injury
S2 Minor Temporary discomfort No treatment needed
S1 Negligible Inconvenience No injury

See: references/risk-analysis-methods.md


Risk Evaluation Workflow

Evaluate risks against acceptability criteria.

Workflow: Evaluate Identified Risks
  1. Calculate initial risk level from probability × severity
  2. Compare to risk acceptability criteria
  3. For each risk, determine:
    • Acceptable: Document and accept (EU MDR: still reduce as far as possible)
    • Reduction required (AFAP): Proceed to risk control
    • Unacceptable: Mandatory risk control
  4. Document evaluation rationale
  5. Identify risks requiring benefit-risk analysis
  6. Complete benefit-risk analysis if applicable
  7. Compile risk evaluation summary
  8. Validation: All risks evaluated; acceptability determined; rationale documented
Risk Evaluation Decision Tree
Risk Estimated
      │
      ▼
Apply Acceptability Criteria
      │
      ├── Low Risk ──────────► Accept and document
      │
      ├── Medium Risk ───────► Reduce as far as possible (AFAP)
      │   │                    Document why further reduction impossible
      │   ▼
      │   Further reduction possible?
      │   │
      │   Yes──► Implement control
      │   No───► Document AFAP rationale (no economic considerations)
      │
      ├── High Risk ─────────► Risk reduction required
      │   │                    Must demonstrate reduction AFAP
      │   ▼
      │   Implement control
      │   Verify residual risk
      │
      └── Unacceptable ──────► Design change mandatory
                               Cannot proceed without control
AFAP Demonstration Requirements (EU MDR)
Criterion Evidence Required
All control options considered Analysis of every feasible control per the hierarchy (design, protective measures, information)
Further reduction impossible Evidence each remaining option is technically infeasible or does not further reduce risk
State of the art Comparison to similar devices and current standards
Stakeholder input Clinical/user perspectives

Economic considerations (cost of further risk reduction) must not enter the EU acceptability decision (MDR Annex I GSPR 2; EN ISO 14971:2019/A11:2021). Cost may inform business decisions about whether to market the device — never whether a risk is acceptable.

Benefit-Risk Analysis Triggers
Situation Benefit-Risk Required
Residual risk remains high Yes
No feasible risk reduction Yes
Novel device Yes
Unacceptable risk with clinical benefit Yes
All risks low No

Risk Control Workflow

Implement and verify risk control measures.

Workflow: Implement Risk Controls
  1. Identify risk control options:
    • Inherent safety by design (Priority 1)
    • Protective measures in device (Priority 2)
    • Information for safety (Priority 3)
  2. Select optimal control following hierarchy
  3. Analyze control for new hazards introduced
  4. Document control in design requirements
  5. Implement control in design
  6. Develop verification protocol
  7. Execute verification and document results
  8. Evaluate residual risk with control in place
  9. Validation: Control implemented; verification passed; residual risk acceptable; no unaddressed new hazards
Risk Control Hierarchy
Priority Control Type Examples Effectiveness
1 Inherent Safety Eliminate hazard, fail-safe design Highest
2 Protective Measures Guards, alarms, automatic shutdown High
3 Information Warnings, training, IFU Lower
Risk Control Option Analysis Template
RISK CONTROL OPTION ANALYSIS

Hazard ID: H-[XXX]
Hazard: [Description]
Initial Risk: P[X] × S[X] = [Level]

OPTIONS CONSIDERED:
| Option | Control Type | New Hazards | Feasibility | Selected |
|--------|--------------|-------------|-------------|----------|
| 1 | [Type] | [Yes/No] | [H/M/L] | [Yes/No] |
| 2 | [Type] | [Yes/No] | [H/M/L] | [Yes/No] |

SELECTED CONTROL: Option [X]
Rationale: [Justification for selection]

IMPLEMENTATION:
- Requirement: [REQ-XXX]
- Design Document: [Reference]

VERIFICATION:
- Method: [Test/Analysis/Review]
- Protocol: [Reference]
- Acceptance Criteria: [Criteria]
Risk Control Verification Methods
Method When to Use Evidence
Test Quantifiable performance Test report
Inspection Physical presence Inspection record
Analysis Design calculation Analysis report
Review Documentation check Review record
Residual Risk Evaluation
After Control Action
Acceptable Document, proceed
Reduced AFAP Document rationale (no economic considerations), proceed
Still unacceptable Additional control or design change
New hazard introduced Analyze and control new hazard

Post-Production Risk Management

Monitor and update risk management throughout product lifecycle.

Workflow: Post-Production Risk Monitoring
  1. Identify information sources:
    • Customer complaints
    • Service reports
    • Vigilance/adverse events
    • Literature monitoring
    • Clinical studies
  2. Establish collection procedures
  3. Define review triggers:
    • New hazard identified
    • Increased frequency of known hazard
    • Serious incident
    • Regulatory feedback
  4. Analyze incoming information for risk relevance
  5. Update risk management file as needed
  6. Communicate significant findings
  7. Conduct periodic risk management review
  8. Validation: Information sources monitored; file current; reviews completed per schedule
Information Sources
Source Information Type Review Frequency
Complaints Use issues, failures Continuous
Service Field failures, repairs Monthly
Vigilance Serious incidents Immediate
Literature Similar device issues Quarterly
Regulatory Authority feedback As received
Clinical PMCF data Per plan
Risk Management File Update Triggers
Trigger Response Time Action
Serious incident Immediate Full risk review
New hazard identified 30 days Risk analysis update
Trend increase 60 days Trend analysis
Design change Before implementation Impact assessment
Standards update Per transition period Gap analysis
Periodic Review Requirements
Review Element Frequency
Risk management file completeness Annual
Risk control effectiveness Annual
Post-market information analysis Quarterly
Risk-benefit conclusions Annual or on new data

Risk Assessment Templates

→ See references/risk-assessment-templates.md for details

Decision Frameworks

Risk Control Selection
What is the risk level?
        │
        ├── Unacceptable ──► Can hazard be eliminated?
        │                    │
        │                Yes─┴─No
        │                 │     │
        │                 ▼     ▼
        │            Eliminate  Can protective
        │            hazard     measure reduce?
        │                           │
        │                       Yes─┴─No
        │                        │     │
        │                        ▼     ▼
        │                   Add       Add warning
        │                   protection + training
        │
        └── High/Medium ──► Apply hierarchy
                            starting at Level 1
New Hazard Analysis
Question If Yes If No
Does control introduce new hazard? Analyze new hazard Proceed
Is new risk higher than original? Reject control option Acceptable trade-off
Can new hazard be controlled? Add control Reject control option
Risk Acceptability Decision
Condition Decision
All risks Low Acceptable
Medium risks reduced AFAP Acceptable
High risks reduced AFAP, documented Acceptable if benefits outweigh
Any Unacceptable residual Not acceptable - redesign

Tools and References

Scripts
Tool Purpose Usage
risk_matrix_calculator.py Calculate risk levels and FMEA RPN python risk_matrix_calculator.py --help

Risk Matrix Calculator Features:

  • ISO 14971 5x5 risk matrix calculation
  • FMEA RPN (Risk Priority Number) calculation
  • Interactive mode for guided assessment
  • Display risk criteria definitions
  • JSON output for integration
References
Document Content
iso14971-implementation-guide.md Complete ISO 14971:2019 implementation with templates
risk-analysis-methods.md FMEA, FTA, HAZOP, Use Error Analysis methods
Quick Reference: ISO 14971 Process
Stage Key Activities Output
Planning Define scope, criteria, responsibilities Risk Management Plan
Analysis Identify hazards, estimate risk Hazard Analysis
Evaluation Compare to criteria, AFAP assessment (EU) Risk Evaluation
Control Implement hierarchy, verify Risk Control Records
Residual Overall assessment, benefit-risk Risk Management Report
Production Monitor, review, update Updated RM File

Skill Integration Point
quality-manager-qms-iso13485 QMS integration
capa-officer Risk-based CAPA
regulatory-affairs-head Regulatory submissions
quality-documentation-manager Risk file management
1---
2name: "risk-management-specialist"
3description: Medical device risk management specialist implementing ISO 14971 throughout product lifecycle. Provides risk analysis, risk evaluation, risk control, and post-production information analysis. Use when user mentions risk management, ISO 14971, risk analysis, FMEA, fault tree analysis, hazard identification, risk control, risk matrix, benefit-risk analysis, residual risk, risk acceptability, or post-market risk.
4---
5 
6# Risk Management Specialist
7 
8ISO 14971:2019 risk management implementation throughout the medical device lifecycle.
9 
10---
11 
12## Table of Contents
13 
14- [Risk Management Planning Workflow](#risk-management-planning-workflow)
15- [Risk Analysis Workflow](#risk-analysis-workflow)
16- [Risk Evaluation Workflow](#risk-evaluation-workflow)
17- [Risk Control Workflow](#risk-control-workflow)
18- [Post-Production Risk Management](#post-production-risk-management)
19- [Risk Assessment Templates](#risk-assessment-templates)
20- [Decision Frameworks](#decision-frameworks)
21- [Tools and References](#tools-and-references)
22 
23---
24 
25## Risk Management Planning Workflow
26 
27Establish risk management process per ISO 14971.
28 
29### Workflow: Create Risk Management Plan
30 
311. Define scope of risk management activities:
32 - Medical device identification
33 - Lifecycle stages covered
34 - Applicable standards and regulations
352. Establish risk acceptability criteria:
36 - Define probability categories (P1-P5)
37 - Define severity categories (S1-S5)
38 - Create risk matrix with acceptance thresholds
393. Assign responsibilities:
40 - Risk management lead
41 - Subject matter experts
42 - Approval authorities
434. Define verification activities:
44 - Methods for control verification
45 - Acceptance criteria
465. Plan production and post-production activities:
47 - Information sources
48 - Review triggers
49 - Update procedures
506. Obtain plan approval
517. Establish risk management file
528. **Validation:** Plan approved; acceptability criteria defined; responsibilities assigned; file established
53 
54### Risk Management Plan Content
55 
56| Section | Content | Evidence |
57|---------|---------|----------|
58| Scope | Device and lifecycle coverage | Scope statement |
59| Criteria | Risk acceptability matrix | Risk matrix document |
60| Responsibilities | Roles and authorities | RACI chart |
61| Verification | Methods and acceptance | Verification plan |
62| Production/Post-Production | Monitoring activities | Surveillance plan |
63 
64### Risk Acceptability Matrix (5x5)
65 
66| Probability \ Severity | Negligible | Minor | Serious | Critical | Catastrophic |
67|------------------------|------------|-------|---------|----------|--------------|
68| **Frequent (P5)** | Medium | High | High | Unacceptable | Unacceptable |
69| **Probable (P4)** | Medium | Medium | High | High | Unacceptable |
70| **Occasional (P3)** | Low | Medium | Medium | High | High |
71| **Remote (P2)** | Low | Low | Medium | Medium | High |
72| **Improbable (P1)** | Low | Low | Low | Medium | Medium |
73 
74### Risk Level Actions
75 
76| Level | Acceptable | Action Required |
77|-------|------------|-----------------|
78| Low | Yes | Document and accept; still reduce as far as possible (EU MDR) |
79| Medium | After reduction AFAP | Reduce as far as possible; document why further reduction is impossible |
80| High | After reduction AFAP | Reduction required; demonstrate all further options exhausted |
81| Unacceptable | No | Design change mandatory |
82 
83> **EU MDR — AFAP, not ALARP:** For CE-marked devices, risks must be reduced **as far as possible (AFAP)** without economic considerations (MDR Annex I, GSPR 1–4; EN ISO 14971:2019/A11:2021 Z-annexes deviation). ALARP ("as low as reasonably practicable"), which permits cost-benefit weighing in acceptability decisions, is **not an acceptable criterion under the EU MDR** — a notified body will flag it. ISO 14971:2019 itself removed ALARP from the normative text. ALARP may persist in some non-EU jurisdictions (e.g., the UK HSE tradition); if used outside the EU, flag the deviation from EU requirements explicitly.
84 
85---
86 
87## Risk Analysis Workflow
88 
89Identify hazards and estimate risks systematically.
90 
91### Workflow: Conduct Risk Analysis
92 
931. Define intended use and reasonably foreseeable misuse:
94 - Medical indication
95 - Patient population
96 - User population
97 - Use environment
982. Select analysis method(s):
99 - FMEA for component/function analysis
100 - FTA for system-level analysis
101 - HAZOP for process deviations
102 - Use Error Analysis for user interaction
1033. Identify hazards by category:
104 - Energy hazards (electrical, mechanical, thermal)
105 - Biological hazards (bioburden, biocompatibility)
106 - Chemical hazards (residues, leachables)
107 - Operational hazards (software, use errors)
1084. Determine hazardous situations:
109 - Sequence of events
110 - Foreseeable misuse scenarios
111 - Single fault conditions
1125. Estimate probability of harm (P1-P5)
1136. Estimate severity of harm (S1-S5)
1147. Document in hazard analysis worksheet
1158. **Validation:** All hazard categories addressed; all hazards documented; probability and severity assigned
116 
117### Hazard Categories Checklist
118 
119| Category | Examples | Analyzed |
120|----------|----------|----------|
121| Electrical | Shock, burns, interference | ☐ |
122| Mechanical | Crushing, cutting, entrapment | ☐ |
123| Thermal | Burns, tissue damage | ☐ |
124| Radiation | Ionizing, non-ionizing | ☐ |
125| Biological | Infection, biocompatibility | ☐ |
126| Chemical | Toxicity, irritation | ☐ |
127| Software | Incorrect output, timing | ☐ |
128| Use Error | Misuse, perception, cognition | ☐ |
129| Environment | EMC, mechanical stress | ☐ |
130 
131### Analysis Method Selection
132 
133| Situation | Recommended Method |
134|-----------|-------------------|
135| Component failures | FMEA |
136| System-level failure | FTA |
137| Process deviations | HAZOP |
138| User interaction | Use Error Analysis |
139| Software behavior | Software FMEA |
140| Early design phase | PHA |
141 
142### Probability Criteria
143 
144| Level | Name | Description | Frequency |
145|-------|------|-------------|-----------|
146| P5 | Frequent | Expected to occur | >10⁻³ |
147| P4 | Probable | Likely to occur | 10⁻³ to 10⁻⁴ |
148| P3 | Occasional | May occur | 10⁻⁴ to 10⁻⁵ |
149| P2 | Remote | Unlikely | 10⁻⁵ to 10⁻⁶ |
150| P1 | Improbable | Very unlikely | <10⁻⁶ |
151 
152### Severity Criteria
153 
154| Level | Name | Description | Harm |
155|-------|------|-------------|------|
156| S5 | Catastrophic | Death | Death |
157| S4 | Critical | Permanent impairment | Irreversible injury |
158| S3 | Serious | Injury requiring intervention | Reversible injury |
159| S2 | Minor | Temporary discomfort | No treatment needed |
160| S1 | Negligible | Inconvenience | No injury |
161 
162See: [references/risk-analysis-methods.md](references/risk-analysis-methods.md)
163 
164---
165 
166## Risk Evaluation Workflow
167 
168Evaluate risks against acceptability criteria.
169 
170### Workflow: Evaluate Identified Risks
171 
1721. Calculate initial risk level from probability × severity
1732. Compare to risk acceptability criteria
1743. For each risk, determine:
175 - Acceptable: Document and accept (EU MDR: still reduce as far as possible)
176 - Reduction required (AFAP): Proceed to risk control
177 - Unacceptable: Mandatory risk control
1784. Document evaluation rationale
1795. Identify risks requiring benefit-risk analysis
1806. Complete benefit-risk analysis if applicable
1817. Compile risk evaluation summary
1828. **Validation:** All risks evaluated; acceptability determined; rationale documented
183 
184### Risk Evaluation Decision Tree
185 
186```
187Risk Estimated
188 │
189 ▼
190Apply Acceptability Criteria
191 │
192 ├── Low Risk ──────────► Accept and document
193 │
194 ├── Medium Risk ───────► Reduce as far as possible (AFAP)
195 │ │ Document why further reduction impossible
196 │ ▼
197 │ Further reduction possible?
198 │ │
199 │ Yes──► Implement control
200 │ No───► Document AFAP rationale (no economic considerations)
201 │
202 ├── High Risk ─────────► Risk reduction required
203 │ │ Must demonstrate reduction AFAP
204 │ ▼
205 │ Implement control
206 │ Verify residual risk
207 │
208 └── Unacceptable ──────► Design change mandatory
209 Cannot proceed without control
210```
211 
212### AFAP Demonstration Requirements (EU MDR)
213 
214| Criterion | Evidence Required |
215|-----------|-------------------|
216| All control options considered | Analysis of every feasible control per the hierarchy (design, protective measures, information) |
217| Further reduction impossible | Evidence each remaining option is technically infeasible or does not further reduce risk |
218| State of the art | Comparison to similar devices and current standards |
219| Stakeholder input | Clinical/user perspectives |
220 
221> Economic considerations (cost of further risk reduction) **must not** enter the EU acceptability decision (MDR Annex I GSPR 2; EN ISO 14971:2019/A11:2021). Cost may inform business decisions about whether to market the device — never whether a risk is acceptable.
222 
223### Benefit-Risk Analysis Triggers
224 
225| Situation | Benefit-Risk Required |
226|-----------|----------------------|
227| Residual risk remains high | Yes |
228| No feasible risk reduction | Yes |
229| Novel device | Yes |
230| Unacceptable risk with clinical benefit | Yes |
231| All risks low | No |
232 
233---
234 
235## Risk Control Workflow
236 
237Implement and verify risk control measures.
238 
239### Workflow: Implement Risk Controls
240 
2411. Identify risk control options:
242 - Inherent safety by design (Priority 1)
243 - Protective measures in device (Priority 2)
244 - Information for safety (Priority 3)
2452. Select optimal control following hierarchy
2463. Analyze control for new hazards introduced
2474. Document control in design requirements
2485. Implement control in design
2496. Develop verification protocol
2507. Execute verification and document results
2518. Evaluate residual risk with control in place
2529. **Validation:** Control implemented; verification passed; residual risk acceptable; no unaddressed new hazards
253 
254### Risk Control Hierarchy
255 
256| Priority | Control Type | Examples | Effectiveness |
257|----------|--------------|----------|---------------|
258| 1 | Inherent Safety | Eliminate hazard, fail-safe design | Highest |
259| 2 | Protective Measures | Guards, alarms, automatic shutdown | High |
260| 3 | Information | Warnings, training, IFU | Lower |
261 
262### Risk Control Option Analysis Template
263 
264```
265RISK CONTROL OPTION ANALYSIS
266 
267Hazard ID: H-[XXX]
268Hazard: [Description]
269Initial Risk: P[X] × S[X] = [Level]
270 
271OPTIONS CONSIDERED:
272| Option | Control Type | New Hazards | Feasibility | Selected |
273|--------|--------------|-------------|-------------|----------|
274| 1 | [Type] | [Yes/No] | [H/M/L] | [Yes/No] |
275| 2 | [Type] | [Yes/No] | [H/M/L] | [Yes/No] |
276 
277SELECTED CONTROL: Option [X]
278Rationale: [Justification for selection]
279 
280IMPLEMENTATION:
281- Requirement: [REQ-XXX]
282- Design Document: [Reference]
283 
284VERIFICATION:
285- Method: [Test/Analysis/Review]
286- Protocol: [Reference]
287- Acceptance Criteria: [Criteria]
288```
289 
290### Risk Control Verification Methods
291 
292| Method | When to Use | Evidence |
293|--------|-------------|----------|
294| Test | Quantifiable performance | Test report |
295| Inspection | Physical presence | Inspection record |
296| Analysis | Design calculation | Analysis report |
297| Review | Documentation check | Review record |
298 
299### Residual Risk Evaluation
300 
301| After Control | Action |
302|---------------|--------|
303| Acceptable | Document, proceed |
304| Reduced AFAP | Document rationale (no economic considerations), proceed |
305| Still unacceptable | Additional control or design change |
306| New hazard introduced | Analyze and control new hazard |
307 
308---
309 
310## Post-Production Risk Management
311 
312Monitor and update risk management throughout product lifecycle.
313 
314### Workflow: Post-Production Risk Monitoring
315 
3161. Identify information sources:
317 - Customer complaints
318 - Service reports
319 - Vigilance/adverse events
320 - Literature monitoring
321 - Clinical studies
3222. Establish collection procedures
3233. Define review triggers:
324 - New hazard identified
325 - Increased frequency of known hazard
326 - Serious incident
327 - Regulatory feedback
3284. Analyze incoming information for risk relevance
3295. Update risk management file as needed
3306. Communicate significant findings
3317. Conduct periodic risk management review
3328. **Validation:** Information sources monitored; file current; reviews completed per schedule
333 
334### Information Sources
335 
336| Source | Information Type | Review Frequency |
337|--------|------------------|------------------|
338| Complaints | Use issues, failures | Continuous |
339| Service | Field failures, repairs | Monthly |
340| Vigilance | Serious incidents | Immediate |
341| Literature | Similar device issues | Quarterly |
342| Regulatory | Authority feedback | As received |
343| Clinical | PMCF data | Per plan |
344 
345### Risk Management File Update Triggers
346 
347| Trigger | Response Time | Action |
348|---------|---------------|--------|
349| Serious incident | Immediate | Full risk review |
350| New hazard identified | 30 days | Risk analysis update |
351| Trend increase | 60 days | Trend analysis |
352| Design change | Before implementation | Impact assessment |
353| Standards update | Per transition period | Gap analysis |
354 
355### Periodic Review Requirements
356 
357| Review Element | Frequency |
358|----------------|-----------|
359| Risk management file completeness | Annual |
360| Risk control effectiveness | Annual |
361| Post-market information analysis | Quarterly |
362| Risk-benefit conclusions | Annual or on new data |
363 
364---
365 
366## Risk Assessment Templates
367→ See references/risk-assessment-templates.md for details
368 
369## Decision Frameworks
370 
371### Risk Control Selection
372 
373```
374What is the risk level?
375 │
376 ├── Unacceptable ──► Can hazard be eliminated?
377 │ │
378 │ Yes─┴─No
379 │ │ │
380 │ ▼ ▼
381 │ Eliminate Can protective
382 │ hazard measure reduce?
383 │ │
384 │ Yes─┴─No
385 │ │ │
386 │ ▼ ▼
387 │ Add Add warning
388 │ protection + training
389 │
390 └── High/Medium ──► Apply hierarchy
391 starting at Level 1
392```
393 
394### New Hazard Analysis
395 
396| Question | If Yes | If No |
397|----------|--------|-------|
398| Does control introduce new hazard? | Analyze new hazard | Proceed |
399| Is new risk higher than original? | Reject control option | Acceptable trade-off |
400| Can new hazard be controlled? | Add control | Reject control option |
401 
402### Risk Acceptability Decision
403 
404| Condition | Decision |
405|-----------|----------|
406| All risks Low | Acceptable |
407| Medium risks reduced AFAP | Acceptable |
408| High risks reduced AFAP, documented | Acceptable if benefits outweigh |
409| Any Unacceptable residual | Not acceptable - redesign |
410 
411---
412 
413## Tools and References
414 
415### Scripts
416 
417| Tool | Purpose | Usage |
418|------|---------|-------|
419| [risk_matrix_calculator.py](scripts/risk_matrix_calculator.py) | Calculate risk levels and FMEA RPN | `python risk_matrix_calculator.py --help` |
420 
421**Risk Matrix Calculator Features:**
422- ISO 14971 5x5 risk matrix calculation
423- FMEA RPN (Risk Priority Number) calculation
424- Interactive mode for guided assessment
425- Display risk criteria definitions
426- JSON output for integration
427 
428### References
429 
430| Document | Content |
431|----------|---------|
432| [iso14971-implementation-guide.md](references/iso14971-implementation-guide.md) | Complete ISO 14971:2019 implementation with templates |
433| [risk-analysis-methods.md](references/risk-analysis-methods.md) | FMEA, FTA, HAZOP, Use Error Analysis methods |
434 
435### Quick Reference: ISO 14971 Process
436 
437| Stage | Key Activities | Output |
438|-------|----------------|--------|
439| Planning | Define scope, criteria, responsibilities | Risk Management Plan |
440| Analysis | Identify hazards, estimate risk | Hazard Analysis |
441| Evaluation | Compare to criteria, AFAP assessment (EU) | Risk Evaluation |
442| Control | Implement hierarchy, verify | Risk Control Records |
443| Residual | Overall assessment, benefit-risk | Risk Management Report |
444| Production | Monitor, review, update | Updated RM File |
445 
446---
447 
448## Related Skills
449 
450| Skill | Integration Point |
451|-------|-------------------|
452| [quality-manager-qms-iso13485](../quality-manager-qms-iso13485/) | QMS integration |
453| [capa-officer](../capa-officer/) | Risk-based CAPA |
454| [regulatory-affairs-head](../regulatory-affairs-head/) | Regulatory submissions |
455| [quality-documentation-manager](../quality-documentation-manager/) | Risk file management |
456 

Discussion

Alternatives

Also in Decision checksSee all 277 in Product →